Axsome Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Axsome Therapeutics, Inc. (AXSM), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are AXSM insiders buying or selling?
Axsome Therapeutics, Inc. insiders reported 16 open-market buys ($1.6M) and 42 sells ($194.5M) across 58 Form 4 filings — a net selling position of $193.0M.
Source: SEC EDGAR Form 4
Key Statistics (as of Sep 3, 2026)
Insider sentiment
Net sellingNet insider flow of $193.0M in net selling.
Recent AXSM insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Mark L. Jacobson | Chief Operating Officer | Sale | 10.0K | $208.65 | $2.1M |
| Aug 7, 2026 | Herriot Tabuteau | Chief Executive Officer | Sale | 49.7K | $212.19 | $10.5M |
| Jul 1, 2026 | Herriot Tabuteau | Chief Executive Officer | Sale | 49.7K | $240.25 | $11.9M |
| Jun 12, 2026 | Roger Jeffs | Director | Sale | 572 | $247.65 | $141.7K |
| Jun 11, 2026 | Susan Mahony | Director | Sale | 600 | $241.70 | $145.0K |
| Jun 11, 2026 | Mark Coleman | Director | Sale | 643 | $249.00 | $160.1K |
| Jun 9, 2026 | Herriot Tabuteau | Chief Executive Officer | Sale | 49.7K | $241.01 | $12.0M |
| Jun 9, 2026 | Nick Pizzie | Chief Financial Officer | Sale | 33.0K | $240.09 | $7.9M |
| Jun 2, 2026 | Mark Coleman | Director | Sale | 17.5K | $229.20 | $4.0M |
| May 6, 2026 | Mark L. Jacobson | Chief Operating Officer | Sale | 4.8K | $227.95 | $1.1M |
| Apr 24, 2026 | Ari Maizel | Chief Commercial Officer | Sale | 7.5K | $182.42 | $1.4M |
| Feb 28, 2026 | Mark Coleman | Director | Sale | 25.0K | $161.11 | $4.0M |
| Feb 28, 2026 | Mark L. Jacobson | Chief Operating Officer | Sale | 35.4K | $161.88 | $5.7M |
| Feb 2, 2026 | Herriot Tabuteau | Chief Executive Officer | Sale | 32.4K | $185.60 | $6.0M |
| Jan 24, 2026 | Nick Pizzie | Chief Financial Officer | Sale | 12.0K | $187.92 | $2.3M |
| Jan 24, 2026 | Ari Maizel | Chief Commercial Officer | Sale | 7.5K | $184.44 | $1.4M |
| Jan 8, 2026 | Herriot Tabuteau | Chief Executive Officer | Sale | 139.4K | $171.30 | $23.9M |
| Jan 3, 2026 | Mark E Saad | Director | Sale | 37.6K | $165.18 | $6.2M |
| Dec 5, 2025 | Herriot Tabuteau | Chief Executive Officer | Sale | 80.0K | $145.66 | $11.6M |
| Nov 6, 2025 | Herriot Tabuteau | Chief Executive Officer | Sale | 163.9K | $133.07 | $21.8M |
| Oct 9, 2025 | Herriot Tabuteau | Chief Executive Officer | Sale | 45.4K | $119.38 | $5.4M |
| Sep 22, 2025 | Mark L. Jacobson | Chief Operating Officer | Sale | 10.0K | $115.96 | $1.2M |
| Sep 17, 2025 | Mark L. Jacobson | Chief Operating Officer | Sale | 45.8K | $114.48 | $5.2M |
| Sep 16, 2025 | Herriot Tabuteau | Chief Executive Officer | Sale | 62.9K | $117.08 | $7.4M |
| Sep 10, 2025 | Mark Coleman | Director | Purchase | 1.6K | $127.28 | $200.5K |
Showing the 25 most recent of 58 Form 4 filings for Axsome Therapeutics, Inc..
Most active AXSM insiders
- Mark Coleman14 filings
- Mark L. Jacobson10 filings
- Nick Pizzie9 filings
- Herriot Tabuteau9 filings
- Roger Jeffs6 filings
Ask anything about AXSM insider activity
Use Trabud's AI agent to query Axsome Therapeutics, Inc.'s Form 4 history in plain English — "Show me AXSM CEO purchases this year" or compare it against any other ticker.
Open the AI agentAXSM insider trading FAQ
Are Axsome Therapeutics, Inc. insiders buying or selling?
Across 58 SEC Form 4 filings, Axsome Therapeutics, Inc. (AXSM) insiders reported 16 open-market purchases totaling $1.6M and 42 sales totaling $194.5M. That is a net selling position of $193.0M.
How many insiders trade AXSM stock?
9 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Axsome Therapeutics, Inc.. The most recent filing was accepted on Sep 3, 2026.
Where does Trabud get AXSM insider trading data?
All AXSM insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.